Teon is a clinical-stage company targeting metabolic signaling pathways and pioneering the development of GPCR immunotherapies in difficult-to-treat cancers.
Location: United States, California, Redwood City
Employees: 11-50
Total raised: $30M
Founded date: 2017
Investors 2
| Date | Name | Website |
| - | MBC BioLab... | mbcbiolabs... |
| 19.03.2022 | Northern L... | nlvc.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 23.02.2021 | Series A | $30M | - |
Mentions in press and media 1
| Date | Title | Description |
| 23.02.2021 | Teon Therapeutics Raises $30M in Series A Financing | Teon Therapeutics, a San Francisco, CA-based biopharmaceutical company developing small molecules that inhibit the immunosuppressive and cancer-promoting signaling pathways, completed a $30M Series A financing. The round was led by Oceanpin... |